The numbers are hard to ignore. In Cook County alone, opioid overdose deaths last year still stand at 683. While Illinois has made real progress since the crisis peaked in 2022, the work is far from done. Pharmacists are often the last healthcare professional a patient sees before a prescribing decision becomes a dispensing decision, but they can’t operate in silos alone.
While many are already familiar with the prescription monitoring program, the tools could be doing more for you with less energy. Prescription monitoring data is most valuable when it doesn’t require pharmacists to leave their native workflow to find it, and when it connects naturally to what comes next. That’s the problem worth solving.
Putting PMP Insights Where Pharmacists Already Work
Controlled substance monitoring capabilities are built around making PMP data more accessible and actionable directly within existing pharmacy management systems. Rather than requiring a separate login or a manual lookup at a separate portal, relevant patient history, risk indicators, and cross-prescriber patterns are surfaced in context, at the point of dispensing, when it matters most.
This means:
- Consolidated patient history across prescribers and dispensing locations, presented clearly within the dispensing workflow
- Risk-relevant indicators drawn from ILPMP data to help support clinical judgment on complex fills
- Audit-ready documentation that reflects the monitoring steps already embedded in your process
When Monitoring Surfaces a Concern, What Happens Next?
Many pharmacy workflows stop at the decision-making phase. But if the patient may be struggling with a substance use disorder, what’s the best long-term pathway to support, and what role can pharmacists play?
That’s where care navigation solutions like Bamboo Bridge comes in.
Bamboo Bridge provides care navigation resources (additional staff support) that can be accessed directly within prescription monitoring workflows. When a controlled substance review raises a concern (such as overlapping prescriptions, escalating dosages, or behavioral indicators), pharmacists can connect patients to behavioral health and recovery support resources without a separate process or referral chain.
This matters because pharmacists are often uniquely positioned to have that conversation. Patients trust their pharmacist. The moment of dispensing is a rare opportunity to introduce a resource that could make a real difference.
A Note on Progress and Why It Shouldn’t Lead to Complacency
The decline in Illinois overdose deaths since 2022 is meaningful and hard-won. State officials have credited sustained naloxone distribution, expanded access to treatment, and improved harm reduction infrastructure for the progress. Prescription monitoring has been part of that picture as research consistently links active PMP programs to reductions in doctor shopping and high-risk prescribing.
But provisional CDC data indicate that even as national opioid deaths declined sharply in 2024, they remain above pre-pandemic levels. And emerging adulterants like xylazine are adding new complexity to an already difficult landscape.
Illinois pharmacists have earned their place as essential partners in this work. The right monitoring infrastructure, one that brings data to the surface and connects it to real support options, can help ensure that partnership is as effective as it can be.
To learn more about our controlled substance monitoring capabilities and how Bamboo Bridge integrates care navigation into your prescription workflow, connect with Bamboo Health at https://bamboohealth.com/contact/.
